2022
DOI: 10.1016/j.biomaterials.2022.121642
|View full text |Cite
|
Sign up to set email alerts
|

Macromolecular crowding in the development of a three-dimensional organotypic human breast cancer model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 118 publications
0
3
0
Order By: Relevance
“…Owing to the importance of the biophysical microenvironment of the tumour ECM in regulating various aspects of cancer cell behaviour including, migration, proliferation and drug resistance [ 28 , 100 ], CDMs represent physiologically relevant and more controllable models for fundamental research on cancer as well as for screening or testing antitumoral drugs. Several matrices derived from either tumour cells or non-tumour cells have been proposed for a variety of tumours, including oral cancer [ 101 ], breast cancer [ 102 , 103 ], myeloma bone disease [ 104 ], ovarian cancer and colorectal cancer [ 105 , 106 ]. Increased proliferation and drug resistance have been frequently reported in cases of tumour cells cultivated in CDMs with respect to cells grown on tissue culture plastic [ 103 , 107 , 108 ].…”
Section: Cell Derived Matricesmentioning
confidence: 99%
See 1 more Smart Citation
“…Owing to the importance of the biophysical microenvironment of the tumour ECM in regulating various aspects of cancer cell behaviour including, migration, proliferation and drug resistance [ 28 , 100 ], CDMs represent physiologically relevant and more controllable models for fundamental research on cancer as well as for screening or testing antitumoral drugs. Several matrices derived from either tumour cells or non-tumour cells have been proposed for a variety of tumours, including oral cancer [ 101 ], breast cancer [ 102 , 103 ], myeloma bone disease [ 104 ], ovarian cancer and colorectal cancer [ 105 , 106 ]. Increased proliferation and drug resistance have been frequently reported in cases of tumour cells cultivated in CDMs with respect to cells grown on tissue culture plastic [ 103 , 107 , 108 ].…”
Section: Cell Derived Matricesmentioning
confidence: 99%
“…Several matrices derived from either tumour cells or non-tumour cells have been proposed for a variety of tumours, including oral cancer [ 101 ], breast cancer [ 102 , 103 ], myeloma bone disease [ 104 ], ovarian cancer and colorectal cancer [ 105 , 106 ]. Increased proliferation and drug resistance have been frequently reported in cases of tumour cells cultivated in CDMs with respect to cells grown on tissue culture plastic [ 103 , 107 , 108 ]. In particular, the differences in cell behaviour and response to drugs have been linked to the stiffer matrices produced by tumour or tumour-associated cells [ 107 , 109 ].…”
Section: Cell Derived Matricesmentioning
confidence: 99%
“…In a diverse range of permanently differentiated and mesenchymal stomal cell culture systems, MMC (i.e., the addition of macromolecules in culture media) has been shown to enhance and accelerate extracellular matrix (ECM) deposition [18,19]. As a direct consequence, tissue engineered medicines [20] and cell derived matrices for cell expansion [21], drug discovery [22], and reparative [23] purposes with superior to the state-of-the-art functionality can now be developed using only a fraction cells and time that traditional approaches require.…”
Section: Introductionmentioning
confidence: 99%